Insider Selling: Inotiv, Inc. (NASDAQ:NOTV) CEO Sells 22,700 Shares of Stock

Inotiv, Inc. (NASDAQ:NOTVGet Free Report) CEO Robert Jr. Leasure sold 22,700 shares of Inotiv stock in a transaction on Friday, January 31st. The shares were sold at an average price of $4.15, for a total value of $94,205.00. Following the transaction, the chief executive officer now owns 1,030,209 shares in the company, valued at $4,275,367.35. This represents a 2.16 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Inotiv Stock Up 1.6 %

Shares of NOTV stock traded up $0.07 on Tuesday, reaching $4.50. 1,028,851 shares of the company’s stock traded hands, compared to its average volume of 613,780. Inotiv, Inc. has a 12-month low of $1.23 and a 12-month high of $11.42. The company has a debt-to-equity ratio of 2.29, a quick ratio of 1.22 and a current ratio of 1.37. The company has a market capitalization of $117.05 million, a P/E ratio of -1.07 and a beta of 3.58. The business’s 50 day moving average price is $4.39 and its two-hundred day moving average price is $2.77.

Inotiv (NASDAQ:NOTVGet Free Report) last issued its earnings results on Tuesday, December 3rd. The company reported ($0.16) EPS for the quarter. Inotiv had a negative net margin of 22.10% and a negative return on equity of 15.86%. On average, equities analysts forecast that Inotiv, Inc. will post -0.75 earnings per share for the current year.

Institutional Trading of Inotiv

Several large investors have recently made changes to their positions in the stock. Geode Capital Management LLC boosted its stake in shares of Inotiv by 7.7% during the 3rd quarter. Geode Capital Management LLC now owns 250,895 shares of the company’s stock worth $427,000 after acquiring an additional 18,039 shares in the last quarter. KPP Advisory Services LLC raised its holdings in Inotiv by 15.8% in the 4th quarter. KPP Advisory Services LLC now owns 275,267 shares of the company’s stock valued at $1,140,000 after acquiring an additional 37,549 shares in the last quarter. Renaissance Technologies LLC raised its holdings in Inotiv by 29.9% in the 2nd quarter. Renaissance Technologies LLC now owns 164,164 shares of the company’s stock valued at $273,000 after acquiring an additional 37,800 shares in the last quarter. AlphaCentric Advisors LLC bought a new stake in shares of Inotiv in the 4th quarter valued at approximately $163,000. Finally, Calamos Advisors LLC bought a new stake in shares of Inotiv in the 4th quarter valued at approximately $275,000. Institutional investors own 18.17% of the company’s stock.

Inotiv Company Profile

(Get Free Report)

Inotiv, Inc provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line.

Recommended Stories

Receive News & Ratings for Inotiv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inotiv and related companies with MarketBeat.com's FREE daily email newsletter.